It includes automation, remote data acquisition, enzyme-linked fluorescence assay (ELFA), chemiluminescence immunoassay (CLIA), capillary electrophoreses (CE) based CLIA, electrochemiluminescence immunoassay (ECLIA), direct access testing and rapid accurate quantification at point of care.
What does CLIA stand for?
CLIA stands for chemiluminescence immunoassay
This definition appears frequently and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
See other definitions of CLIA
We have 27 other meanings of CLIA in our Acronym Attic
- Current Law Index
- Customer Loyalty Index
- Cutter Life Index (engineering/geology)
- Client Input/Output Sockets (IBM)
- California Lodging Industry Association
- Camp Leaders in America (Cultural Homestay International)
- Canadian Lawyers Insurance Association (Toronto, Ontario, Canada)
- Canadian Livestock Identification Agency (Canada)
- Central Lack of Intelligence Agency (Meet the Fokkers movie)
- Certified Landscape Irrigation Auditor
- Christian Legal Intervention Academy (London, Ontario, Canada)
- Civil Liberties Impact Assessment (US DHS)
- Clandestine Laboratory Investigators Association (Honolulu, HI)
- Clinical Laboratory Improvement Act/Amendment
- Community Legal Information Association (Charlottetown, Prince Edward Island, Canada)
- Coon Lake Improvement Association (Minnesota)
- Cruise Lines International Association
- Clinical Laboratory Improvement Amendments of 1988
- Clinical Laboratory Improvement Advisory Committee (Centers for Disease Control and Prevention)
- Community Legal Information Association of Prince Edward Island (Canada)
Samples in periodicals archive:
It also reflects the challenge of bringing to market new immunodiagnostics, not just ELISAs but other platforms such as chemiluminescence immunoassays and flow cytometry.
The PATHFAST point-of-care chemiluminescence immunoassay analyzer system is a unique, self-contained, bench-top analyzer that rapidly measures concentrations of emergency bio-markers from a single whole blood sample.
Recent CAP data (CAP survey, 2006 Ligands Special) indicate that clinical laboratories using chemiluminescence immunoassays can report a result ranging from 41 to 96 [micro]g/L for a survey sample with a value of 31 [micro]g/L determined by LC-MS/MS (BGS-04 in Fig.